Economy Shares Technology Uncategorized

Co Diagnostics Declines Almost 10%, Posts Q3 Results

Co-Diagnostics Inc. (Nasdaq: CODX) a molecular diagnostics business having a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the 3rd quarter finished September 30, 2020 and supplied updates on Company developments, including receipt of CE markings for both the recently developed Logix Smart ABC (Influenza